Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Kramer

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of the Pediatric Infectious Diseases Society|May 18, 2026
Impact of nirsevimab implementation on the mid-term burden of bronchiolitis in the outpatient setting: results from the prospective OURSYN studyLea Lenglart, Corinne Levy, Fabienne Cahn-Sellem, et al.
The Pediatric Infectious Disease Journal|November 15, 2023
Respiratory Syncytial Virus in Outpatient Children with Bronchiolitis: Continuous Virus Circulation During the Nonepidemic PeriodAlexis Rybak, Robert Cohen, Rolf Kramer, et al.
The Journal of Infectious Diseases|November 7, 2023
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control StudyCaren van Roekel, Eero Poukka, Topi Turunen, et al.
The Journal of Pediatrics|March 20, 2026
Effectiveness of Nirsevimab on Primary Care Visits for RSV-Associated Acute Otitis Media in InfantsLea Lenglart, Corinne Levy, Christophe Batard, et al.
European Journal of Pediatrics|February 1, 2025
Nirsevimab effectiveness on paediatric emergency visits for RSV bronchiolitis: a test-negative design studyLea Lenglart, Corinne Levy, Romain Basmaci, et al.
International Journal of Antimicrobial Agents|October 7, 2021
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involvedLoïc Simon, Tanguy Déméautis, Damien Dupont, et al.
JAMA Network Open|October 30, 2025
Nirsevimab Treatment of RSV Bronchiolitis in Pediatric Emergency DepartmentsLea Lenglart, Corinne Levy, Romain Basmaci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 3, 2026
Primary care RSV disease characteristics in infants and young children in Germany, data from the prospective PAPI surveillance network, 2021-2023Alexander Kiefer, David Twardella, Jessica Bähre, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 27, 2025
Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023Arantxa Urchueguía-Fornes, Richard Osei-Yeboah, Ombeline Jollivet, et al.
The Lancet Regional Health. Europe|February 25, 2025
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyCaroline Klint Johannesen, David Gideonse, Richard Osei-Yeboah, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of the Pediatric Infectious Diseases Society|May 18, 2026
Impact of nirsevimab implementation on the mid-term burden of bronchiolitis in the outpatient setting: results from the prospective OURSYN studyLea Lenglart, Corinne Levy, Fabienne Cahn-Sellem, et al.
The Pediatric Infectious Disease Journal|November 15, 2023
Respiratory Syncytial Virus in Outpatient Children with Bronchiolitis: Continuous Virus Circulation During the Nonepidemic PeriodAlexis Rybak, Robert Cohen, Rolf Kramer, et al.
The Journal of Infectious Diseases|November 7, 2023
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control StudyCaren van Roekel, Eero Poukka, Topi Turunen, et al.
The Journal of Pediatrics|March 20, 2026
Effectiveness of Nirsevimab on Primary Care Visits for RSV-Associated Acute Otitis Media in InfantsLea Lenglart, Corinne Levy, Christophe Batard, et al.
European Journal of Pediatrics|February 1, 2025
Nirsevimab effectiveness on paediatric emergency visits for RSV bronchiolitis: a test-negative design studyLea Lenglart, Corinne Levy, Romain Basmaci, et al.
International Journal of Antimicrobial Agents|October 7, 2021
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involvedLoïc Simon, Tanguy Déméautis, Damien Dupont, et al.
JAMA Network Open|October 30, 2025
Nirsevimab Treatment of RSV Bronchiolitis in Pediatric Emergency DepartmentsLea Lenglart, Corinne Levy, Romain Basmaci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 3, 2026
Primary care RSV disease characteristics in infants and young children in Germany, data from the prospective PAPI surveillance network, 2021-2023Alexander Kiefer, David Twardella, Jessica Bähre, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 27, 2025
Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023Arantxa Urchueguía-Fornes, Richard Osei-Yeboah, Ombeline Jollivet, et al.
The Lancet Regional Health. Europe|February 25, 2025
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyCaroline Klint Johannesen, David Gideonse, Richard Osei-Yeboah, et al.
Pageof 4